Recro Pharma, Inc. is a pharmaceutical company, whcih is focused on products for hospitals and ambulatory care settings. The company is developing non-opioid products for treatment of serious acute pain. It offers drug solutions for cancer, musculoskeletal disorders and peripheral neuropathy, cancer breakthrough and acute post-operative pain. The company's products include Dex-INR and Fadolmidine, which is under development. Recro Pharma was founded by Geraldine A. Henwood on November 15, 2007 and is headquartered in Malvern, PA.
Market Cap | 61.122 Million | Shares Outstanding | 84.892 Million | Avg 30-day Volume | 106.307 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.06 |
Price to Revenue | 0.0 | Debt to Equity | 2.3187 | EBITDA | 7.98 Million |
Price to Book Value | 0.0 | Operating Margin | 0.5467 | Enterprise Value | 0 |
Current Ratio | 3.244 | EPS Growth | 0.776 | Quick Ratio | 2.094 |
1 Yr BETA | 0.8049 | 52-week High/Low | 1.86 / 0.62 | Profit Margin | -15.0876 |
Operating Cash Flow Growth | 34.5977 | Altman Z-Score | 0.0 | Free Cash Flow to Firm | -42.383 Million |
Earnings Report | 2023-08-09 |
Please sign in first
none
370 Thousand total shares from 1 transactions
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
LAKE RYAN DAVID CHIEF FINANCIAL OFFICER |
|
777,398 | 2023-05-31 | 16 |
|
239,102 | 2023-05-17 | 1 | |
|
241,400 | 2023-05-17 | 1 | |
|
228,549 | 2023-05-17 | 1 | |
|
246,102 | 2023-05-17 | 1 | |
|
190,043 | 2023-05-17 | 1 | |
|
161,120 | 2023-05-17 | 1 | |
|
73,620 | 2023-05-17 | 3 | |
|
10,126,144 | 2023-04-28 | 3 | |
ENLOE J DAVID JR CHIEF EXECUTIVE OFFICER |
|
2,266,300 | 2023-01-19 | 8 |
|
282,228 | 2022-05-18 | 0 | |
|
38,012 | 2021-04-20 | 0 | |
|
2,097,938 | 2020-12-22 | 0 | |
|
701,017 | 2020-12-22 | 0 | |
|
1,128,303 | 2020-05-07 | 0 | |
|
44,196 | 2019-12-05 | 0 | |
|
39,283 | 2019-12-05 | 0 | |
CELANO MICHAEL CHIEF OPERATING OFFICER |
|
44,063 | 2019-01-18 | 0 |
|
No longer subject to file | 2018-05-24 | 0 | |
MYERS DIANE SENIOR VP-REG/QUALITY |
|
18,528 | 2018-01-18 | 0 |
MACK RANDALL SENIOR VP, DEVELOPMENT |
|
33,752 | 2018-01-18 | 0 |
MCCALLUM STEWART CHIEF MEDICAL OFFICER |
|
31,841 | 2018-01-18 | 0 |
GRAFF FRED CHIEF COMMERCIAL OFFICER |
|
27,083 | 2018-01-18 | 0 |
MATTILA JYRKI EXECUTIVE VP, BUSINESS DEV. |
|
11,500 | 2018-01-02 | 0 |
|
No longer subject to file | 2017-06-12 | 0 | |
|
No longer subject to file | 2017-05-12 | 0 | |
NICHOLS DONNA CAO/CONTROLLER |
|
0 | 2017-01-18 | 0 |
|
0 | 2015-12-16 | 0 | |
GARNER CHARLES CFO AND CHIEF BUSINESS OFFICER |
|
5,000 | 2015-06-05 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-06-02 16:31:06 -0400 | 2023-05-31 | F | 1,197 | $0.70 | d | 777,398 | direct | |||||||||
2023-05-19 16:57:02 -0400 | 2023-05-17 | A | 27,229 | a | 27,229 | direct | ||||||||||
2023-05-19 16:58:02 -0400 | 2023-05-17 | A | 73,620 | a | 190,043 | direct | 18.0556 | 5.5556 | 18.0556 | 2 | 0.0 | 1 | ||||
2023-05-19 16:58:02 -0400 | 2023-05-17 | A | 27,229 | a | 27,229 | direct | ||||||||||
2023-05-19 16:57:33 -0400 | 2023-05-17 | A | 73,620 | a | 239,102 | direct | 18.0556 | 5.5556 | 18.0556 | 2 | 0.0 | 1 | ||||
2023-05-19 16:57:33 -0400 | 2023-05-17 | A | 27,229 | a | 27,229 | direct | ||||||||||
2023-05-19 16:56:43 -0400 | 2023-05-17 | A | 73,620 | a | 241,400 | direct | 18.0556 | 5.5556 | 18.0556 | 2 | 0.0 | 1 | ||||
2023-05-19 16:56:43 -0400 | 2023-05-17 | A | 27,229 | a | 27,229 | direct | ||||||||||
2023-05-19 16:57:02 -0400 | 2023-05-17 | A | 73,620 | a | 73,620 | direct | 18.0556 | 5.5556 | 18.0556 | 2 | 0.0 | 1 | ||||
2023-05-19 16:54:52 -0400 | 2023-05-17 | A | 73,620 | a | 246,102 | direct | 18.0556 | 5.5556 | 18.0556 | 2 | 0.0 | 1 | ||||
2023-05-19 16:54:52 -0400 | 2023-05-17 | A | 27,229 | a | 27,229 | direct | ||||||||||
2023-05-19 16:55:10 -0400 | 2023-05-17 | A | 73,620 | a | 228,549 | direct | 18.0556 | 5.5556 | 18.0556 | 2 | 0.0 | 1 | ||||
2023-05-19 16:55:10 -0400 | 2023-05-17 | A | 27,229 | a | 27,229 | direct | ||||||||||
2023-05-19 16:54:04 -0400 | 2023-05-17 | A | 73,620 | a | 161,120 | direct | 18.0556 | 5.5556 | 18.0556 | 2 | 0.0 | 1 | ||||
2023-05-19 16:54:04 -0400 | 2023-05-17 | A | 27,229 | a | 27,229 | direct | ||||||||||
2023-05-03 16:09:57 -0400 | 2023-05-01 | F | 1,198 | $0.74 | d | 778,595 | direct | 0.0 | -2.1429 | 0.0 | 1 | -2.1429 | 6 | |||
AWM INVESTMENT COMPANY, INC. - > 10% Owner by limited partnerships |
2023-04-27 17:03:33 -0400 | 2023-04-27 | S | 370,000 | $0.70 | d | 8,476,052 | indirect | 1.3699 | -4.1096 | 1.3699 | 2 | -4.1096 | 4 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
SOCIETAL CDMO INC SCTL | 2023-06-05 22:15:04 UTC | 3.6954 | 1.3646 | 150000 |
SOCIETAL CDMO INC SCTL | 2023-06-05 21:45:04 UTC | 3.6954 | 1.3646 | 150000 |
SOCIETAL CDMO INC SCTL | 2023-06-05 21:15:04 UTC | 3.6954 | 1.3646 | 150000 |
SOCIETAL CDMO INC SCTL | 2023-06-05 20:45:04 UTC | 3.6954 | 1.3646 | 150000 |
SOCIETAL CDMO INC SCTL | 2023-06-05 20:15:05 UTC | 3.6954 | 1.3646 | 150000 |
SOCIETAL CDMO INC SCTL | 2023-06-05 19:45:04 UTC | 3.6954 | 1.3646 | 150000 |
SOCIETAL CDMO INC SCTL | 2023-06-05 19:15:04 UTC | 3.6954 | 1.3646 | 150000 |
SOCIETAL CDMO INC SCTL | 2023-06-05 18:45:03 UTC | 3.6954 | 1.3646 | 150000 |
SOCIETAL CDMO INC SCTL | 2023-06-05 18:15:04 UTC | 3.6954 | 1.3646 | 150000 |
SOCIETAL CDMO INC SCTL | 2023-06-05 17:45:03 UTC | 3.6954 | 1.3646 | 150000 |
SOCIETAL CDMO INC SCTL | 2023-06-05 17:15:03 UTC | 3.6954 | 1.3646 | 150000 |
SOCIETAL CDMO INC SCTL | 2023-06-05 16:45:03 UTC | 3.775 | 1.285 | 150000 |
SOCIETAL CDMO INC SCTL | 2023-06-05 16:15:04 UTC | 3.775 | 1.285 | 150000 |
SOCIETAL CDMO INC SCTL | 2023-06-05 15:45:04 UTC | 3.775 | 1.285 | 150000 |
SOCIETAL CDMO INC SCTL | 2023-06-05 15:15:04 UTC | 3.775 | 1.285 | 150000 |
SOCIETAL CDMO INC SCTL | 2023-06-05 14:45:04 UTC | 3.775 | 1.285 | 150000 |
SOCIETAL CDMO INC SCTL | 2023-06-05 14:15:04 UTC | 3.775 | 1.285 | 150000 |
SOCIETAL CDMO INC SCTL | 2023-06-05 13:45:04 UTC | 3.775 | 1.285 | 150000 |
SOCIETAL CDMO INC SCTL | 2023-06-05 13:15:04 UTC | 3.775 | 1.285 | 150000 |
SOCIETAL CDMO INC SCTL | 2023-06-05 12:45:03 UTC | 3.775 | 1.285 | 150000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|